186 related articles for article (PubMed ID: 38199135)
1. Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1.
Mohan S; Hakami MA; Dailah HG; Khalid A; Najmi A; Zoghebi K; Halawi MA
Pathol Res Pract; 2024 Feb; 254():155041. PubMed ID: 38199135
[TBL] [Abstract][Full Text] [Related]
2. Expression Analysis of Long Noncoding RNA-MALAT1 and Interleukin-6 in Inflammatory Bowel Disease Patients.
Nemati Bajestan M; Piroozkhah M; Chaleshi V; Ghiasi NE; Jamshidi N; Mirfakhraie R; Balaii H; Shahrokh S; Asadzadeh Aghdaei H; Salehi Z; Nazemalhosseini Mojarad E
Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):482-494. PubMed ID: 38085149
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of long noncoding RNAs in autoimmune diseases.
Wu GC; Pan HF; Leng RX; Wang DG; Li XP; Li XM; Ye DQ
Autoimmun Rev; 2015 Sep; 14(9):798-805. PubMed ID: 25989481
[TBL] [Abstract][Full Text] [Related]
4. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
5. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.
Tsai CY; Shen CY; Liu CW; Hsieh SC; Liao HT; Li KJ; Lu CS; Lee HT; Lin CS; Wu CH; Kuo YM; Yu CL
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33291347
[TBL] [Abstract][Full Text] [Related]
7. Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.
Cardamone G; Paraboschi EM; Soldà G; Cantoni C; Supino D; Piccio L; Duga S; Asselta R
Hum Mol Genet; 2019 May; 28(9):1414-1428. PubMed ID: 30566690
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of SnoRNAs in the pathogenesis and treatment of autoimmune disorders.
Dubey G; Singh M; Singh H; Agarwal M; Chandel SS; Mishra A; Singh RP; Kukreti N
Pathol Res Pract; 2024 Jan; 253():154952. PubMed ID: 38000202
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.
Goyal B; Yadav SRM; Awasthee N; Gupta S; Kunnumakkara AB; Gupta SC
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188502. PubMed ID: 33428963
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in autoimmune diseases with skin involvement.
Deng X; Su Y; Wu H; Wu R; Zhang P; Dai Y; Chan TM; Zhao M; Lu Q
Scand J Immunol; 2015 Mar; 81(3):153-65. PubMed ID: 25430682
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
[TBL] [Abstract][Full Text] [Related]
12. Integrated Transcriptome Profiling Revealed That Elevated Long Non-Coding RNA-
You Y; Zhao X; Wu Y; Mao J; Ge L; Guo J; Zhao C; Chen D; Song Z
Front Immunol; 2021; 12():615859. PubMed ID: 34220794
[TBL] [Abstract][Full Text] [Related]
13. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
14. From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression.
Thapa R; Afzal O; Afzal M; Gupta G; Bhat AA; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Arora P; Singh SK; Dua K
Pathol Res Pract; 2024 Jan; 253():154959. PubMed ID: 38029713
[TBL] [Abstract][Full Text] [Related]
15. [Decreased long-chain non-coding RNA MALAT1 expression and increased hsa-miR155-3p expression involved in Notch signaling pathway regulation in rheumatoid arthritis patients].
Wan L; Liu J; Huang C; Zhao L; Jiang H; Liu L; Sun Y; Xin L; Zheng L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jun; 36(6):535-541. PubMed ID: 32696744
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Role of Non-Coding RNAs in the Pathophysiology of Systemic Lupus Erythematosus.
Taheri M; Eghtedarian R; Dinger ME; Ghafouri-Fard S
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32580306
[TBL] [Abstract][Full Text] [Related]
17. Circulating long noncoding RNAs as novel bio-tools: Focus on autoimmune diseases.
Karimi B; Dehghani Firoozabadi A; Peymani M; Ghaedi K
Hum Immunol; 2022; 83(8-9):618-627. PubMed ID: 35717260
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.
Shomali N; Suliman Maashi M; Baradaran B; Daei Sorkhabi A; Sarkesh A; Mohammadi H; Hemmatzadeh M; Marofi F; Sandoghchian Shotorbani S; Jarahian M
Front Immunol; 2022; 13():839945. PubMed ID: 35309327
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signature of regulatory T cells in health and autoimmunity.
Soltanzadeh-Yamchi M; Shahbazi M; Aslani S; Mohammadnia-Afrouzi M
Biomed Pharmacother; 2018 Apr; 100():316-323. PubMed ID: 29453041
[TBL] [Abstract][Full Text] [Related]
20. Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.
D'Amico F; Skarmoutsou E; Lo LJ; Granata M; Trovato C; Rossi GA; Bellocchi C; Marchini M; Scorza R; Mazzarino MC; Keinan A
Immunol Lett; 2017 Jan; 181():58-62. PubMed ID: 27888057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
